Oral Formulation of 5-Aminosalicylic Acid-Hemoglobin Bio-Adhesive Nanoparticles Enhance Therapeutic Efficiency in Ulcerative Colitis Mice: A Preclinical Evaluation

•In vivo-evaluated 5-ASA-HbNPs as a colon-specific prodrug for treatment of experimental colitis.•HbNPs conjugation is an efficient way to increase the therapeutic effect and to reduce the adverse effects of 5-ASA.•HbNPs acted as not only a pro-moiety but also a therapeutically active agent.•Mucoadh...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of pharmaceutical sciences 2024-08, Vol.113 (8), p.2331-2341
Hauptverfasser: Vaezi, Zahra, Baradaran Ghavami, Shaghayegh, Farmani, Maryam, Mahdavian, Reza, Asadzadeh Aghdaei, Hamid, Naderi-Manesh, Hossein
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•In vivo-evaluated 5-ASA-HbNPs as a colon-specific prodrug for treatment of experimental colitis.•HbNPs conjugation is an efficient way to increase the therapeutic effect and to reduce the adverse effects of 5-ASA.•HbNPs acted as not only a pro-moiety but also a therapeutically active agent.•Mucoadhesive property of this colonic nano-delivery system contributed to the treatment of IBD. The oral formulation design for colon-specific drug delivery brings some therapeutic benefits in the ulcerative colitis treatment. We recently reported the specific delivery of hemoglobin nanoparticles-conjugating 5-aminosalicylic acid (5-ASA-HbNPs) to the inflamed site. In the current study, the therapeutic effect of the 5-ASA-HbNPs formulation was confirmed in vivo. This evaluation of 5-ASA-HbNPs not only shows longer colonic retention time due to adhesive properties, also provides full support for it as compared with free 5-ASA. It was considered as a suitable bio-adhesive nanoparticle with mucoadhesive property to pass through the mucus layer and accumulate into the mucosa. In UC model mice, a two-fold decrease in the disease activity indexes and colon weight/length ratios was significantly observed in the group treated with 5-ASA-HbNPs. This group received one percent of the standard dosage of 5-ASA (50 μg/kg), while, a similar result was observed for a significant amount of free 5-ASA (5 mg/kg). Furthermore, microscopic images of histological sections of the extracted colons demonstrated that the 5-ASA-HbNPs and 5-ASA groups displayed instances of inflammatory damage within the colon. However, in comparison to the colitis group, the extent of this damage was relatively moderate, suggesting 5-ASA-HbNPs improved therapeutic efficacy with the lower dosage form. [Display omitted]
ISSN:0022-3549
1520-6017
1520-6017
DOI:10.1016/j.xphs.2024.03.028